Valuation GlaxoSmithKline plc Liquidnet

Stocks

Delayed Liquidnet			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

09:35pm	FTSE 100 outperforms as oil price heads lower	AN
09:28pm	European Stocks Close Mostly Lower in Monday Trading; US Treasury Secretary Scott Bessent to Give Details on Iran Sanctions	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	75,753	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	3.49%	-	-
Enterprise Value (EV) ¹	1,00,296	75,578	74,152	68,039	87,654	95,591	92,813	89,818
Change	-	-24.65%	-1.89%	-8.24%	28.83%	9.05%	-2.91%	-3.23%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.3x	11.7x	10.9x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.62x	4.04x	3.56x
PEG	-	0x	-0.2x	-0.4x	0x	-2.29x	0.5x	1.57x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.23x	2.13x	2.07x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.82x	2.61x	2.45x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.34x	7.57x	7.08x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.28x	8.4x	7.8x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.2x	16x	13.2x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.81%	6.24%	7.57%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7495	0.7831
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.68%	3.96%	4.14%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.323	1.616	1.728
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	52.6%	46.4%	45.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,936	35,515	36,639
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,464	12,256	12,693
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,298	11,044	11,519
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,436	6,484	6,933
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	19,838	17,060	14,065
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.90	18.90	18.90
Nbr of stocks (in thousands)	40,06,383	40,60,999	40,76,145	40,80,519	40,12,126	40,07,011	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,11900Cr
JOHNSON & JOHNSON	30.06x	-	-	1.99%	65TCr
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	47TCr
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	37TCr
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	30TCr
ASTRAZENECA PLC	21.46x	4.4x	12.56x	2%	26TCr
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	24TCr
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	21TCr
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	18TCr
Average	17.94x	6.80x	16.24x	2.32%	42.22TCr
Weighted average by Cap.	25.52x	8.51x	18.71x	1.9%